-
公开(公告)号:EP3139922A4
公开(公告)日:2017-12-27
申请号:EP15788649
申请日:2015-05-05
申请人: UNIV EMORY
IPC分类号: A61K31/44 , A61K31/495 , A61K31/4965 , A61P31/06
CPC分类号: G01N33/56972 , A61K31/133 , A61K31/4409 , A61K31/496 , A61K31/4965 , A61K45/06 , G01N33/5091 , G01N2333/35 , G01N2333/47 , G01N2333/57 , G01N2333/70514 , G01N2333/70539 , G01N2333/70596 , G01N2800/26 , A61K2300/00
摘要: This disclosure relates to methods of treating and diagnosing a tuberculosis infection as pulmonary active or latent based on biomarkers expressed on pools of CD4+ cells. In certain embodiments, the disclosure relates to methods of treatment of a subject diagnosed with tuberculosis comprising the steps of, measuring a pool of CD4 IFN-γ cells for cells that also express CD38, HLA-DR, and/or Ki-67 providing a measurement; associating an increased measurement of CD4 IFN-γ cells that also express CD38, HLA-DR, Ki-67, compared to a control, as an indication that the subject has active tuberculosis; and treating the subject with an aggressive tuberculosis treatment.